US Broker Ratings

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with 6% Upside Potential

McKesson Corporation (NYSE: MCK) stands tall as a pillar in the healthcare sector, primarily operating within the medical distribution industry. With a robust market capitalization of $89.11 billion, the company..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings and Promising 5.41% Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust portfolio spanning medical devices, diagnostics, pharmaceuticals, and nutritional products. Headquartered..

Edwards Lifesciences Corporatio (EW)

⚠️ No article content returned.

..

Stryker Corporation (SYK) Investor Outlook: Navigating a 9.79% Potential Upside in Medical Devices

Stryker Corporation (NYSE: SYK) stands as a formidable player in the healthcare sector, prominently known for its innovation in medical devices. With a robust market capitalization of $146.71 billion, Stryker..

Sanofi (SNY) Investor Outlook: Potential 27% Upside Amid Robust Dividend Yield

Sanofi (NYSE: SNY), a titan in the healthcare sector, continues to capture investor attention with its promising outlook and substantial dividend yield. Headquartered in Paris, France, Sanofi operates globally, providing..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Navigating 19.2% Revenue Growth and Future Prospects

Investors eyeing the healthcare sector might find Intuitive Surgical, Inc. (NASDAQ: ISRG) an intriguing proposition, given its substantial $199.67 billion market cap and impressive 19.2% revenue growth. The company, renowned..

Elevance Health, Inc. (ELV) Stock Analysis: Unpacking a 27% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans sector, is drawing attention from investors with a substantial market capitalization of $88.87 billion. This health benefits company, previously..

Danaher Corporation (DHR) Stock Analysis: Uncovering a 26% Upside Potential Amidst Healthcare Dominance

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, has consistently commanded investor attention with its robust portfolio spanning biotechnology, life sciences, and diagnostics. With a market capitalization of..

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 15.51% Potential Upside with Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio of prescription medicines and strategic innovations. With a market capitalization of..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a Potential 215% Upside in Biotech

MBX Biosciences, Inc. (NASDAQ: MBX) is capturing significant attention in the biotechnology sector, particularly among investors seeking high-growth opportunities in the healthcare industry. The company, based in Carmel, Indiana, was..

PureTech Health plc (PRTC) Stock Analysis: Unveiling a 183% Potential Upside in Biotech Innovation

PureTech Health plc (NASDAQ: PRTC), a burgeoning entity in the biotechnology sector, is capturing the attention of investors with its remarkable potential upside of 183.24%. With a focus on developing..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Potential 379.95% Upside in the Biotech Sector

For investors with a keen eye on the healthcare sector, Prothena Corporation plc (PRTA) offers a compelling opportunity within the biotechnology industry. Based in Dublin, Ireland, Prothena is a late-stage..

Tourmaline Bio, Inc. (TRML) Stock Analysis: Healthcare Innovator with a 194.87% Potential Upside

Tourmaline Bio, Inc. (NASDAQ: TRML), a biotechnology firm at the forefront of developing treatments for immune and inflammatory diseases, has captured investor attention with a remarkable potential upside of 194.87%,..

COMPASS Pathways Plc (CMPS) Stock Analysis: A Potential 271% Upside in the Healthcare Sector

COMPASS Pathways Plc (NASDAQ: CMPS) is catching the attention of investors, with a remarkable potential upside of 271.26% based on the average analyst target price of $16.82. For those exploring..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 68.61% Potential Upside for Investors

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a U.S.-based leader in the medical devices sector, presents an intriguing opportunity for investors with its potential 68.61% upside. Specializing in innovative solutions for..

AngioDynamics, Inc. (ANGO) Stock Analysis: Investor Outlook Reveals 42.94% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacture of innovative medical devices aimed at treating peripheral vascular disease, oncology, and surgical..

Altimmune, Inc. (ALT) Stock Analysis: Unlocking a 277.75% Potential Upside in Biotech

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is attracting significant attention from investors, particularly due to its bold foray into the treatment of obesity and metabolic diseases. With a..

Autolus Therapeutics plc (AUTL) Stock Analysis: Harnessing a 341% Potential Upside in Biotech Innovation

Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company based in the United Kingdom, is capturing the attention of investors with its transformative approach to cancer and autoimmune disease treatments...

Maze Therapeutics, Inc. (MAZE) Investor Outlook: An 87% Upside Potential in Biotech Innovation

Maze Therapeutics, Inc. (MAZE), a burgeoning entity within the biotechnology sector, is capturing attention with its compelling growth potential and strategic focus on precision medicines. With a market capitalization of..

Abivax SA (ABVX) Stock Analysis: Unlocking a Potential 355% Upside in Biotechnology

Abivax SA (ABVX), a prominent player in the biotechnology sector, is grabbing the spotlight with a potential upside of 355.74%, according to analysts’ target price projections. Headquartered in Paris, France,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds